NASDAQ:CCRN - Cross Country Healthcare Stock Price, Price Target & More

$12.47 -0.07 (-0.56 %)

(As of 04/25/2018 06:35 AM ET)

Previous Close$12.54

Today's Range$12.24 - $12.68

52-Week Range$9.07 - $15.09

Volume162,846 shs

Average Volume162,126 shs

Market Capitalization$453.41 million

P/E Ratio20.56

Dividend YieldN/A

Beta0.91

About Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare, Inc. provides healthcare staffing, recruiting, and workforce solutions in the United States. The company operates in three segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing; short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and travel allied professionals on long-term contract assignments. It serves public and private acute care hospitals, government-owned facilities, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, retailers, and other healthcare providers under the Cross Country Staffing, Mediscan, and DirectEd brands. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Medical Doctor Associates brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The Other Human Capital Management Services segment offers retained and contingent search services for physicians, healthcare executives, nurses, advanced practice, and allied health professionals. Cross Country Healthcare, Inc. was founded in 1996 and is headquartered in Boca Raton, Florida.

Receive CCRN News and Ratings via Email

Sign-up to receive the latest news and ratings for CCRN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Help supply services

Sub-IndustryHealth Care Services

SectorBusiness Services

SymbolNASDAQ:CCRN

CUSIP22748310

Webwww.crosscountryhealthcare.com

Phone800-347-2264

Debt

Debt-to-Equity Ratio0.39%

Current Ratio2.21%

Quick Ratio2.21%

Price-To-Earnings

Trailing P/E Ratio20.56

Forward P/E Ratio24.94

P/E Growth2.23

Sales & Book Value

Annual Sales$865.05 million

Price / Sales0.52

Cash Flow$0.8844 per share

Price / Cash14.10

Book Value$6.52 per share

Price / Book1.91

Profitability

EPS (Most Recent Fiscal Year)$0.61

Net Income$37.51 million

Net Margins4.34%

Return on Equity10.24%

Return on Assets5.16%

Miscellaneous

Employees1,800

Outstanding Shares36,160,000

How to Become a New Pot Stock Millionaire

Cross Country Healthcare (NASDAQ:CCRN) Frequently Asked Questions

What is Cross Country Healthcare's stock symbol?

Cross Country Healthcare trades on the NASDAQ under the ticker symbol "CCRN."

How were Cross Country Healthcare's earnings last quarter?

Cross Country Healthcare, Inc. (NASDAQ:CCRN) released its quarterly earnings results on Wednesday, February, 28th. The business services provider reported $0.17 EPS for the quarter, missing the Zacks' consensus estimate of $0.19 by $0.02. The business services provider earned $219.67 million during the quarter, compared to the consensus estimate of $225.60 million. Cross Country Healthcare had a net margin of 4.34% and a return on equity of 10.24%. The company's revenue for the quarter was down 1.3% compared to the same quarter last year. During the same period in the prior year, the business earned $0.20 EPS. View Cross Country Healthcare's Earnings History.

When is Cross Country Healthcare's next earnings date?

Cross Country Healthcare is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for Cross Country Healthcare.

What guidance has Cross Country Healthcare issued on next quarter's earnings?

Cross Country Healthcare updated its first quarter earnings guidance on Wednesday, February, 28th. The company provided EPS guidance of $0.01-0.03 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.09. The company issued revenue guidance of $205-210 million, compared to the consensus revenue estimate of $226.77 million.

What price target have analysts set for CCRN?

9 equities research analysts have issued 12-month target prices for Cross Country Healthcare's stock. Their predictions range from $13.00 to $19.00. On average, they expect Cross Country Healthcare's stock price to reach $15.4286 in the next year. View Analyst Ratings for Cross Country Healthcare.

What are Wall Street analysts saying about Cross Country Healthcare stock?

Here are some recent quotes from research analysts about Cross Country Healthcare stock:

1. According to Zacks Investment Research, "Cross Country Healthcare, Inc. is a national leader in providing innovative healthcare workforce solutions and staffing services. Their diverse client base includes both clinical and nonclinical settings, servicing acute care hospitals, physician practice groups, outpatient and ambulatory-care centers, nursing facilities, both public schools and charter schools, rehabilitation and sports medicine clinics, government facilities, and homecare. They are able to place clinicians on travel and per diem assignments, local short-term contracts and permanent positions. They are a market leader in providing flexible workforce management solutions, which include managed services programs (MSP), internal resource pool consulting and development, electronic medical record (EMR) transition staffing, recruitment process outsourcing, predictive modeling and other outsourcing and consultative services. " (1/17/2018)
2. Cantor Fitzgerald analysts commented, "CCRN positioned the July 2017 acquisition of Advantage RN as a positive, and 3Q17 results released 11/1 bear that out, with stronger revenue and higher margins than we had expected (on a pro-forma basis)." (11/1/2017)

Who are some of Cross Country Healthcare's key competitors?

Some companies that are related to Cross Country Healthcare include TTEC (TTEC), Kelly Services (KELYA), TrueBlue (TBI), Kelly Services (KELYB), Kforce (KFRC), Barrett Business Services (BBSI), STHREE (STREF), StarTek (SRT), DLH (DLHC), RCM Technologies (RCMT), Hudson Global (HSON), Command Center (CCNI), Staffing 360 Solutions (STAF), Tapinator (TAPM) and Corporate Resource Services (CRRSQ).

Who are Cross Country Healthcare's key executives?

Cross Country Healthcare's management team includes the folowing people:

Mr. William J. Grubbs, CEO, Pres & Director (Age 60)
Mr. Christopher R. Pizzi, Sr. VP, CFO & Principal Accounting Officer (Age 47)
Mr. William J. Burns, Exec. VP & COO (Age 48)
Ms. Susan E. Ball J.D., MBA, RN, Exec. VP, Gen. Counsel & Sec. (Age 54)
Mr. William G. Halnon, Chief Information Officer (Age 59)

Has Cross Country Healthcare been receiving favorable news coverage?

Media stories about CCRN stock have trended somewhat positive recently, according to Accern. The research firm scores the sentiment of news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Cross Country Healthcare earned a media sentiment score of 0.14 on Accern's scale. They also assigned news articles about the business services provider an impact score of 45.21 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

How do I buy shares of Cross Country Healthcare?

Shares of CCRN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cross Country Healthcare's stock price today?

One share of CCRN stock can currently be purchased for approximately $12.47.

How big of a company is Cross Country Healthcare?

Cross Country Healthcare has a market capitalization of $453.41 million and generates $865.05 million in revenue each year. The business services provider earns $37.51 million in net income (profit) each year or $0.61 on an earnings per share basis. Cross Country Healthcare employs 1,800 workers across the globe.

How can I contact Cross Country Healthcare?

Cross Country Healthcare's mailing address is 5201 CONGRESS AVENUE SUITE 100B, BOCA RATON FL, 33487. The business services provider can be reached via phone at 800-347-2264 or via email at [email protected]

MarketBeat Community Rating for Cross Country Healthcare (CCRN)

Community Ranking:		3.0 out of 5 ( )
Outperform Votes:		288 (Vote Outperform)
Underperform Votes:		193 (Vote Underperform)
Total Votes:		481

MarketBeat's community ratings are surveys of what our community members think about Cross Country Healthcare and other stocks. Vote "Outperform" if you believe CCRN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CCRN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Cross Country Healthcare (NASDAQ:CCRN) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

9 Wall Street analysts have issued ratings and price targets for Cross Country Healthcare in the last 12 months. Their average twelve-month price target is $15.4286, suggesting that the stock has a possible upside of 23.73%. The high price target for CCRN is $19.00 and the low price target for CCRN is $13.00. There are currently 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Hold."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Hold	Hold	Buy	Buy
Consensus Rating Score:	2.44	2.38	2.83	2.83
Ratings Breakdown:	0 Sell Rating(s) 5 Hold Rating(s) 4 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 5 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 5 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 5 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$15.4286	$15.50	$15.6667	$16.0833
Price Target Upside:	23.73% upside	37.53% upside	33.22% upside	26.84% upside

Cross Country Healthcare (NASDAQ:CCRN) Consensus Price Target History

Price Target History for Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/18/2018	Barrington Research	Initiated Coverage	Outperform	$15.00	Medium
3/6/2018	BMO Capital Markets	Reiterated Rating	Outperform -> Outperform	$14.00 -> $13.00	Medium
3/2/2018	Lake Street Capital	Reiterated Rating	Buy -> Hold		High
3/2/2018	Cantor Fitzgerald	Downgrade	Overweight -> Neutral		High
3/2/2018	SunTrust Banks	Reiterated Rating	Buy		High
3/1/2018	Benchmark	Downgrade	Buy -> Hold	$19.00	High
2/1/2018	Jefferies Group	Initiated Coverage	Hold -> Hold	$15.00	Low
11/7/2017	Credit Suisse Group	Initiated Coverage	Neutral -> Neutral	$13.00	N/A
6/14/2017	UBS	Reiterated Rating	Buy	$16.50 -> $15.00	N/A
1/24/2017	Avondale Partners	Downgrade	Outperform -> Market Perform	$15.50	N/A

(Data available from 4/25/2016 forward)

Cross Country Healthcare (NASDAQ:CCRN) Earnings History and Estimates Chart

Earnings by Quarter for Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) Earnings Estimates

2018 EPS Consensus Estimate: $0.54
2019 EPS Consensus Estimate: $0.79

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	4	$0.02	$0.11	$0.04
Q2 2018	4	$0.10	$0.17	$0.13
Q3 2018	4	$0.16	$0.18	$0.17
Q4 2018	4	$0.19	$0.22	$0.20
Q1 2019	1	$0.10	$0.10	$0.10
Q2 2019	1	$0.19	$0.19	$0.19
Q3 2019	1	$0.23	$0.23	$0.23
Q4 2019	1	$0.27	$0.27	$0.27

Cross Country Healthcare (NASDAQ CCRN) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/1/2018		$0.06					N/A
2/28/2018	Q4 2017	$0.19	$0.17	$225.60 million	$219.67 million	View	N/A
11/1/2017	Q3 2017	$0.18	$0.23	$228.97 million	$228.50 million	View	N/A
8/2/2017	Q2 2017	$0.09	$0.16	$209.92 million	$209.31 million	View	Listen
5/3/2017	Q1 2017	$0.0120	$0.05	$212.43 million	$207.57 million	View	Listen
3/1/2017	Q416	$0.22	$0.20	$210.96 million	$222.52 million	View	Listen
11/2/2016	Q316	$0.15	$0.24	$203.09 million	$214.99 million	View	Listen
8/3/2016	Q216	$0.13	$0.16	$203.56 million	$199.40 million	View	Listen
5/4/2016	Q116	$0.07	$0.09	$196.94 million	$196.58 million	View	N/A
3/9/2016	Q415	$0.19	$0.18	$196.26 million	$193.10 million	View	Listen
11/4/2015	Q315	$0.10	$0.23	$193.84 million	$195.69 million	View	Listen
8/5/2015	Q215	$0.06	$0.10	$190.81 million	$192.60 million	View	Listen
5/6/2015	Q115	$0.03	$0.03	$187.00 million	$185.96 million	View	Listen
3/4/2015	Q414	$0.04	$0.03	$190.90 million	$188.10 million	View	Listen
11/5/2014	Q314	$0.02	$0.07	$188.30 million	$188.90 million	View	Listen
8/6/2014	Q214	($0.01)	$0.01	$123.72 million	$122.66 million	View	N/A
5/7/2014	Q114	($0.01)	($0.03)	$120.21 million	$118.10 million	View	N/A
11/7/2013	Q313	($0.01)	$0.05	$111.93 million	$108.00 million	View	N/A
8/6/2013	Q2 2013	($0.01)	($0.05)	$110.75 million	$110.80 million	View	N/A
5/7/2013	Q1 2013		($0.01)	$111.77 million	$110.30 million	View	N/A
3/18/2013	Q4 2012	($0.01)	($0.31)	$126.52 million	$111.73 million	View	N/A
11/6/2012	Q312	$0.02	($0.02)	$128.79 million	$129.10 million	View	N/A
8/6/2012		$0.04	($0.08)			View	N/A
3/5/2012		$0.05	$0.04			View	N/A
11/2/2011		$0.04	$0.06			View	N/A
8/3/2011		$0.04	$0.05			View	N/A
5/5/2011		$0.01	$0.01			View	N/A
3/9/2011		$0.02	$0.02			View	N/A
11/1/2010	Q3 2010	$0.03	$0.03			View	N/A
8/4/2010	Q2 2010	$0.03	$0.04			View	N/A
5/5/2010	Q1 2010	$0.02	$0.04			View	N/A
3/3/2010	Q4 2009	$0.03	$0.05			View	N/A
11/2/2009	Q3 2009	$0.02	$0.03			View	N/A
8/5/2009	Q2 2009	$0.05	$0.07			View	N/A
5/6/2009	Q1 2009	$0.09	$0.10			View	N/A
3/4/2009	Q4 2008	$0.16	$0.18			View	N/A
11/3/2008	Q3 2008	$0.20	$0.20			View	N/A
8/5/2008	Q2 2008	$0.20	$0.21			View	N/A
5/7/2008	Q1 2008	$0.16	$0.19			View	N/A
3/3/2008	Q4 2007	$0.22	$0.23			View	N/A

(Earnings results data provided by Zacks Investment Research)

Cross Country Healthcare (NASDAQ:CCRN) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Cross Country Healthcare (NASDAQ CCRN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.40%
Institutional Ownership Percentage: 95.10%

Insider Trading History for Cross Country Healthcare (NASDAQ:CCRN)

Institutional Ownership by Quarter for Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ CCRN) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/5/2018	W Larry Cash	Director	Buy	5,000	$11.23	$56,150.00	113,580
3/5/2018	William J Grubbs	CEO	Buy	10,000	$11.18	$111,800.00	353,741
12/8/2017	Susan E Ball	General Counsel	Sell	25,000	$14.19	$354,750.00	126,921
11/6/2017	Thomas C Dircks	Director	Buy	10,000	$11.77	$117,700.00	104,571
8/24/2017	William J Grubbs	Insider	Sell	49,113	$12.16	$597,214.08	395,188
11/18/2016	Vickie Anenberg	Insider	Sell	40,882	$14.92	$609,959.44	173,717
11/16/2016	Vickie Anenberg	Insider	Sell	4,800	$15.04	$72,192.00	190,717
8/17/2016	Thomas C Dircks	Director	Buy	10,000	$10.75	$107,500.00	95,264
8/12/2016	W Larry Cash	Director	Buy	3,000	$12.22	$36,660.00	99,253
8/10/2016	William J Burns	CFO	Buy	1,000	$12.04	$12,040.00	107,059
8/10/2016	William J Grubbs	Insider	Buy	10,000	$12.03	$120,300.00	347,892
6/13/2016	Deborah A Dean	SVP	Sell	6,868	$14.34	$98,487.12	46,214
3/14/2016	Thomas C Dircks	Director	Buy	12,000	$11.05	$132,600.00	78,001
3/14/2016	William J Burns	CFO	Buy	2,600	$11.05	$28,730.00	79,432
3/14/2016	William J Grubbs	CEO	Buy	10,000	$11.46	$114,600.00	238,395
11/27/2015	Susan E Ball	General Counsel	Sell	40,000	$18.00	$720,000.00	93,469
11/27/2015	Vickie Anenberg	insider	Sell	8,105	$17.83	$144,512.15	131,519
11/18/2015	Paul Tymchuk	Insider	Sell	3,000	$17.50	$52,500.00	36,745
6/15/2015	Vickie Anenberg	Insider	Sell	10,756	$12.00	$129,072.00
6/12/2015	Vickie Anenberg	Insider	Sell	13,563	$11.73	$159,093.99
3/9/2015	William J Grubbs	CEO	Buy	10,000	$10.74	$107,400.00
11/10/2014	William J Grubbs	CEO	Buy	5,000	$9.68	$48,400.00
9/26/2014	Emil Hensel	Director	Sell	7,000	$9.11	$63,770.00
9/5/2014	Emil Hensel	Director	Sell	5,000	$8.49	$42,450.00
9/4/2014	Joseph Trunfio	Director	Buy	12,400	$8.15	$101,060.00
8/13/2014	Emil Hensel	Director	Sell	5,000	$7.98	$39,900.00
8/11/2014	William J Grubbs	CEO	Buy	15,000	$7.45	$111,750.00
7/30/2014	Emil Hensel	Director	Sell	9,310	$7.22	$67,218.20
6/10/2014	Paul Tymchuk	Insider	Buy	3,000	$6.64	$19,920.00
6/6/2014	Joseph Trunfio	Director	Buy	14,400	$6.72	$96,768.00
6/6/2014	Susan E Ball	General Counsel	Buy	1,500	$6.72	$10,080.00
6/5/2014	Emil Hensel	Director	Sell	3,000	$6.75	$20,250.00
5/21/2013	William J Grubbs	COO	Buy	10,000	$5.25	$52,500.00
5/16/2013	Jonathan W Ward	CMO	Sell	18,695	$5.14	$96,092.30

(Data available from 1/1/2013 forward)

Cross Country Healthcare (NASDAQ CCRN) News Headlines

Source:

Date	Headline
	Cross Country Healthcare (CCRN) Stock Rating Upgraded by BidaskClub www.americanbankingnews.com - April 25 at 12:26 AM
	New Research: Key Drivers of Growth for Cross Country Healthcare, Tribune ... globenewswire.com - April 24 at 4:36 PM
	Cross Country Healthcare (CCRN) to Release Quarterly Earnings on Tuesday www.americanbankingnews.com - April 24 at 8:05 AM
	Cross Country Healthcare (CCRN) Raised to "Hold" at ValuEngine www.americanbankingnews.com - April 23 at 11:18 PM
	Barrington Research Weighs in on Cross Country Healthcare, Inc.'s Q1 2018 Earnings (CCRN) www.americanbankingnews.com - April 23 at 1:22 AM
	$206.24 Million in Sales Expected for Cross Country Healthcare, Inc. (CCRN) This Quarter www.americanbankingnews.com - April 21 at 1:56 AM
	Cross Country Healthcare (CCRN) Given Buy Rating at UBS www.americanbankingnews.com - April 20 at 9:46 PM
	Analysts Anticipate Cross Country Healthcare, Inc. (CCRN) to Announce $0.02 Earnings Per Share www.americanbankingnews.com - April 19 at 11:14 PM
	Cross Country Healthcare (CCRN) Receives New Coverage from Analysts at Barrington Research www.americanbankingnews.com - April 18 at 10:38 AM
	Cross Country Healthcare (CCRN) Downgraded to "Strong Sell" at BidaskClub www.americanbankingnews.com - April 16 at 7:00 PM
	Cross Country Healthcare, Inc. (CCRN) Receives Average Rating of "Hold" from Analysts www.americanbankingnews.com - April 15 at 5:43 PM
	Benchmark Trims Cross Country Healthcare (CCRN) Target Price to $17.00 www.americanbankingnews.com - April 13 at 5:29 PM
	Benchmark Reiterates Buy Rating for Cross Country Healthcare (CCRN) www.americanbankingnews.com - April 12 at 3:58 PM
	Cross Country Healthcare (CCRN) Rating Lowered to C+ at TheStreet www.americanbankingnews.com - April 11 at 9:21 AM
	Madden Joins Cejka Executive Search as Executive Vice President, Managing Principal finance.yahoo.com - April 10 at 9:58 AM
	BidaskClub Upgrades Cross Country Healthcare (CCRN) to "Buy" www.americanbankingnews.com - April 7 at 7:02 AM
	Cross Country Healthcare Announces First Quarter 2018 Earnings Release Date and Conference Call Information finance.yahoo.com - April 4 at 5:08 PM
	Zacks: Analysts Expect Cross Country Healthcare, Inc. (CCRN) Will Announce Quarterly Sales of $206.24 Million www.americanbankingnews.com - April 4 at 1:54 AM
	ValuEngine Downgrades Cross Country Healthcare (CCRN) to Sell www.americanbankingnews.com - April 3 at 5:52 PM
	$0.02 Earnings Per Share Expected for Cross Country Healthcare, Inc. (CCRN) This Quarter www.americanbankingnews.com - April 2 at 11:12 PM
	Credit Suisse Group Initiates Coverage on Cross Country Healthcare (CCRN) www.americanbankingnews.com - April 1 at 3:10 PM
	Edited Transcript of CCRN earnings conference call or presentation 1-Mar-18 2:00pm GMT finance.yahoo.com - March 30 at 4:25 PM
	Flavor Of The Month: Innoviva And More finance.yahoo.com - March 29 at 4:23 PM
	Cross Country Healthcare (CCRN): Moving Average Crossover Alert finance.yahoo.com - March 29 at 9:58 AM
	Cross Country Healthcare (CCRN) Now Covered by Analysts at Jefferies Group www.americanbankingnews.com - March 25 at 10:56 PM
	Cross Country Healthcare (CCRN) Downgraded by BidaskClub www.americanbankingnews.com - March 25 at 12:50 AM
	Cross Country Healthcare (CCRN) Downgraded by Benchmark www.americanbankingnews.com - March 24 at 2:12 PM
	Cross Country Healthcare, Inc. (CCRN) Given Average Rating of "Hold" by Analysts www.americanbankingnews.com - March 21 at 5:33 PM
	Cross Country Healthcare, Inc. (CCRN) Expected to Announce Earnings of $0.02 Per Share www.americanbankingnews.com - March 16 at 9:04 PM
	Global NGS in Agrigenomics Market Anticipated to Reach $1.4 Billion by 2021, Reports BIS Research www.prnewswire.com - March 15 at 9:29 AM
	What Falling Estimates & Price Mean for Cross Country Healthcare (CCRN) www.zacks.com - March 15 at 9:29 AM
	Insider Buys: Cross Country Healthcare And Four Other Stocks www.forbes.com - March 14 at 5:35 PM
	Cantor Fitzgerald Weighs in on Cross Country Healthcare, Inc.'s FY2018 Earnings (CCRN) www.americanbankingnews.com - March 7 at 11:48 AM
	Cross Country Healthcare (CCRN) PT Lowered to $13.00 at BMO Capital Markets www.americanbankingnews.com - March 6 at 11:00 AM
	Cross Country Healthcare Inc (CCRN) President and CEO William J Grubbs Bought $111,800 of Shares finance.yahoo.com - March 6 at 9:26 AM
	Insider Buying: Cross Country Healthcare, Inc. (CCRN) Director Buys 5,000 Shares of Stock www.americanbankingnews.com - March 5 at 9:48 PM
	Cross Country Healthcare, Inc. (CCRN) CEO Purchases $111,800.00 in Stock www.americanbankingnews.com - March 5 at 3:16 PM
	Q3 2018 EPS Estimates for Cross Country Healthcare, Inc. (CCRN) Decreased by Analyst www.americanbankingnews.com - March 5 at 4:28 AM
	Q1 2018 Earnings Forecast for Cross Country Healthcare, Inc. Issued By Oppenheimer (CCRN) www.americanbankingnews.com - March 5 at 2:42 AM
	Q1 2018 EPS Estimates for Cross Country Healthcare, Inc. (CCRN) Cut by Analyst www.americanbankingnews.com - March 5 at 2:40 AM
	Citadel Advisors LLC Has $1.17 Million Position in Cross Country Healthcare, Inc. (CCRN) www.americanbankingnews.com - March 4 at 5:18 AM
	Cross Country Healthcare (CCRN) Earns "Buy" Rating from SunTrust Banks www.americanbankingnews.com - March 3 at 8:22 PM
	Cross Country Healthcare (CCRN) Lowered to Neutral at Cantor Fitzgerald www.americanbankingnews.com - March 3 at 4:50 PM
	Cross Country Healthcare (CCRN) Raised to B at TheStreet www.americanbankingnews.com - March 3 at 1:56 PM
	Cross Country Healthcare (CCRN) Downgraded to "Hold" at Lake Street Capital www.americanbankingnews.com - March 2 at 7:48 PM
	Q2 2018 Earnings Estimate for Cross Country Healthcare, Inc. Issued By Oppenheimer (CCRN) www.americanbankingnews.com - March 2 at 10:24 AM
	Cortina Asset Management LLC Has $5.45 Million Position in Cross Country Healthcare, Inc. (CCRN) www.americanbankingnews.com - March 1 at 11:53 AM
	Cross Country Healthcare Q4 miss sinks shares, down 26% seekingalpha.com - March 1 at 10:58 AM
	Cross Country Healthcare, Inc. to Host Earnings Call finance.yahoo.com - March 1 at 9:16 AM
	Cross Country misses Street 4Q forecasts finance.yahoo.com - March 1 at 9:16 AM

Cross Country Healthcare (NASDAQ:CCRN) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Cross Country Healthcare (NASDAQ:CCRN) Income Statement, Balance Sheet and Cash Flow Statement

Cross Country Healthcare (NASDAQ CCRN) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff